糖尿病与衰弱相关研究进展

doi:10.3969/j.issn.1003-9198.2022.07.003

摘要/Abstract

中图分类号:

R592
R587.1

仰孝群, 欧阳晓俊. 糖尿病与衰弱相关研究进展[J]. 实用老年医学, 2022, 36(7): 655-659.

[1] SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183(10267):109119.
[2] LI Y, TENG D, SHI X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369:m997.
[3] KALYANI R R, VARADHAN R, WEISS C O, et al. Frailty status and altered glucose-insulin dynamics[J]. J Gerontol A Biol Sci Med Sci, 2012, 67(12):1300-1306.
[4] ABDELHAFIZ A H, KOAY L, SINCLAIR A J. The emergence of frailty may lead to a state of burnt out type 2 diabetes[J]. J Frailty Aging, 2016, 5(3):162-167.
[5] KONG L N, LYU Q, YAO H Y, et al. The prevalence of frailty among community-dwelling older adults with diabetes: a meta-analysis[J]. Int J Nurs Stud, 2021, 119:103952.
[6] CHHETRI J K, ZHENG Z, XU X, et al. The prevalence and incidence of frailty in pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II) [J]. BMC Geriatr, 2017, 17(1):47.
[7] HANLON P, FAUR I, CORCORAN N, et al. Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis[J]. Lancet Healthy Longev, 2020, 1(3):e106-e116.
[8] LIN C L, YU N C, WU H C, et al. Risk factors associated with frailty in older adults with type 2 diabetes: a cross-sectional study[J]. J Clin Nurs, 2022, 31(7/8):967-974.
[9] KANG S, OH T J, CHO B L, et al. Sex differences in sarcopenia and frailty among community-dwelling Korean older adults with diabetes: the Korean frailty and aging cohort study[J]. J Diabetes Investig, 2021, 12(2):155-164.
[10] LOPEZ-GARCIA E, HAGAN K A, FUNG T T, et al. Mediterranean diet and risk of frailty syndrome among women with type 2 diabetes[J]. Am J Clin Nutr, 2018, 107(5):763-771.
[11] HAZUDA H P, PAN Q, FLOREZ H, et al. Association of intensive lifestyle and metformin interventions with frailty in the diabetes prevention program outcomes study[J]. J Gerontol A Biol Sci Med Sci, 2021, 76(5):929-936.
[12] BAK E, MŁYNARSKA A, MARCISZ C, et al. The influence of frailty syndrome on quality of life in elderly patients with type 2 diabetes[J]. Qual Life Res, 2021, 30(9):2487-2495.
[13] CACCIATORE F, TESTA G, GALIZIA G, et al. Clinical frailty and long-term mortality in elderly subjects with diabetes[J]. Acta Diabetologica, 2013, 50(2):251-260.
[14] FERRI-GUERRA J, APARICIO-UGARRIZA R, SALGUERO D, et al. The association of frailty with hospitalizations and mortality among community dwelling older adults with diabetes[J]. J Frailty Aging, 2020, 9(2):94-100.
[15] ABDELHAFIZ A H, SINCLAIR A J. Cognitive frailty in older people with type 2 diabetes mellitus: the central role of hypoglycaemia and the need for prevention[J]. Curr Diab Rep, 2019, 19(4):15.
[16] ALEXOPOULOS A S, KAHKOSKA A R, PATE V, et al. Deintensification of treatment with sulfonylurea and insulin after severe hypoglycemia among older adults with diabetes[J]. JAMA Netw Open, 2021, 4(11):e2132215.
[17] CHUNG S M, LEE Y H, KIM C O, et al. Daytime glycemic variability and frailty in older patients with diabetes: a pilot study using continuous glucose monitoring[J]. J Korean Med Sci, 2021, 36(27):e190.
[18] WANG X, CHEN Z, LI Z, et al. Association between frailty and risk of fall among diabetic patients [J]. Endocr Connect, 2020, 9(10):1057-1064.
[19] LI G, PRIOR J C, LESLIE W D, et al. Frailty and risk of fractures in patients with type 2 diabetes[J]. Diabetes Care, 2019, 42(4):507-513.
[20] SOYSAL P, STUBBS B, LUCATO P, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis[J]. Ageing Res Rev, 2016, 31:1-8.
[21] AL-SOFIANI M E, GANJI S S, KALYANI R R. Body composition changes in diabetes and aging[J]. J Diabetes Complications, 2019, 33(6):451-459.
[22] ALABADI B, CIVERA M, DE LA ROSA A, et al. Frailty is associated with oxidative stress in older patients with type 2 diabetes[J]. Nutrients, 2021, 13(11):3983.
[23] CALVANI R, RODRIGUEZ-MANAS L, PICCA A, et al. Identification of a circulating amino acid signature in frail older persons with type 2 diabetes mellitus: results from the metabofrail study[J]. Nutrients, 2020, 12(1):199.
[24] OKUN J G, RUSU P M, CHAN A Y, et al. Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes[J]. Nat Metab, 2021, 3(3):394-409.
[25] OH G, KONCEVICˇIUS K, EBRAHIMI S, et al. Circadian oscillations of cytosine modification in humans contribute to epigenetic variability, aging, and complex disease[J]. Genome Biol, 2019, 20(1):2.
[26] BOURDEL-MARCHASSON I, CATHELINE G, REGUEME S, et al. Frailty and brain-muscle correlates in older people with type 2 diabetes: a structural-MRI explorative study[J]. J Nutr Health Aging, 2019, 23(7):637-640.
[27] XU Y S, LIU X J, LIU X X, et al. The roles of the gut microbiota and chronic low-grade inflammation in older adults with frailty[J]. Front Cell Infect Microbiol, 2021, 11:675414.
[28] COKE L A, DENNISON HIMMELFARB C R. Type 2 diabetes in the older adult: the need for assessment of frailty[J]. J Cardiovasc Nurs, 2017, 32(6):511-513.
[29] ABDELHAFIZ A H, KOAY L, SINCLAIR A J. The effect of frailty should be considered in the management plan of older people with type 2 diabetes[J]. Future Sci OA, 2016, 2(1):FSO102.
[30] GOBBENS R J, UCHMANOWICZ I. Assessing frailty with the Tilburg Frailty Indicator (TFI): a review of reliability and validity[J]. Clin Interv Aging, 2021, 16:863-875.
[31] ABDELHAFIZ A H, PETERS S, SINCLAIR A J. Low glycaemic state increases risk of frailty and functional decline in older people with type 2 diabetes mellitus - Evidence from a systematic review[J]. Diabetes Res Clin Pract, 2021, 181:109085.
[32] NGUYEN T N, HARRIS K, WOODWARD M, et al. The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type 2 diabetes: results from the ADVANCE trial [J]. Diabetes Care, 2021, 44(7):1622-1629.
[33] JIA W, WENG J, ZHU D, et al. Standards of medical care for type 2 diabetes in China 2019[J]. Diabetes Metab Res Rev, 2019, 35(6):e3158.
[34] STRAIN W D, DOWN S, BROWN P, et al. Diabetes and frailty: an expert consensus statement on the management of older adults with type 2 diabetes[J]. Diabetes Ther, 2021, 12(5):1227-1247.
[35] American Diabetes Association Professional Practice Committee. 13. Older adults: standards of medical care in diabetes—2022[J]. Diabetes Care, 2021, 45(Suppl 1):S195-S207.
[36] ESPINOZA S E, MUSI N, WANG C P, et al. Rationale and study design of a randomized clinical trial of metformin to prevent frailty in older adults with prediabetes [J]. J Gerontol A Biol Sci Med Sci, 2020, 75(1):102-109.
[37] WANG C P, LORENZO C, HABIB S L, et al. Differential effects of metformin on age related comorbidities in older men with type 2 diabetes[J]. J Diabetes Complications, 2017, 31(4):679-686.
[38] ZULLO A R, SMITH R J, GUTMAN R, et al. Comparative safety of dipeptidyl peptidase-4 inhibitors and sulfonylureas among frail older adults[J]. J Am Geriatr Soc, 2021, 69(10):2923-2930.
[39] DAVE C V, SCHNEEWEISS S, KIM D, et al. Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study[J]. Ann Intern Med, 2019, 171(4):248-256.
[40] FRALICK M, KIM S C, SCHNEEWEISS S, et al. Fracture risk after initiation of use of canagliflozin: a cohort study[J]. Ann Intern Med, 2019, 170(3):155-163.
[41] BAHAT G, CATIKKAS N M, KARAN M A, et al. Management of type 2 diabetes mellitus in older adults: eight case studies with focus SGLT-2 inhibitors and metformin[J]. Acta Clin Belg, 2021. DOI: 10.1080/17843286.2021.1952379.
[42] EMMERTON D, ABDELHAFIZ A. Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people[J]. Hosp Pract, 2021, 49(3):164-175.
[43] TAMURA Y, OMURA T, TOYOSHIMA K, et al. Nutrition management in older adults with diabetes: a review on the importance of shifting prevention strategies from metabolic syndrome to frailty[J]. Nutrients, 2020, 12(11):3367.
[44] HAYAKAWA M, MOTOKAWA K, MIKAMI Y, et al. Low dietary variety and diabetes mellitus are associated with frailty among community-dwelling older japanese adults: A Cross-Sectional Study[J]. Nutrients, 2021, 13(2):641.
[45] DE SOUSA M V, DA SILVA SOARES D B, CARA A E R, et al. Dietary protein and exercise for preservation of lean mass and perspectives on type 2 diabetes prevention[J]. Exp Biol Med: Maywood, 2019, 244(12):992-1004.
[46] RODRIGUEZ-MANAS L, LAOSA O, VELLAS B, et al. Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus[J]. J Cachexia Sarcopenia Muscle, 2019, 10(4):721-733.
[47] IZQUIERDO M, LAOSA O, CADORE E L, et al. Two-year follow-up of a multimodal intervention on functional capacity and muscle power in frail patients with type 2 diabetes[J]. J Am Med Dir Assoc, 2021, 22(9):1906-1911.
[48] ISHII M, YAMAGUCHI Y, HAMAYA H, et al. Influence of oral health on frailty in patients with type 2 diabetes aged 75 years or older[J]. BMC Geriatr, 2022, 22(1):145.
[49] KHAN R I, NIRZHOR S S R, AKTER R. A review of the recent advances made with SIRT6 and its implications on aging related processes, major human diseases, and possible therapeutic targets[J]. Biomolecules, 2018, 8(3):44.
[50] ROICHMAN A, ELHANATI S, AON M A, et al. Restoration of energy homeostasis by SIRT6 extends healthy lifespan[J]. Nat Commun, 2021, 12(1):3208.

糖尿病与衰弱相关研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	张飞, 张孔雁, 王佳贺. 前言——口腔衰弱与常见老年综合征关系的研究进展[J]. 实用老年医学, 2024, 38(9): 865-866.
[2]	李净兵, 王会军, 王少颖, 赵璨, 王莉迪, 曹玉娇. 己酮可可碱联合硫辛酸对老年衰弱综合征病人躯体功能及生活质量的影响[J]. 实用老年医学, 2024, 38(8): 812-815.
[3]	刘雅婷, 陈琼, 孔彦洁, 彭云, 洪丹, 彭琳琳, 胡兰, 陈霞, 张星, 刘丽华, 南亚昀. 3种跌倒风险自评工具在住院老年病人中应用的信效度及预测价值分析[J]. 实用老年医学, 2024, 38(6): 572-576.
[4]	李詹, 周凯云, 鲍凤香, 陈玉伦. 太极拳结合抗阻训练应用于养老机构老年衰弱病人的研究[J]. 实用老年医学, 2022, 36(12): 1277-1280.
[5]	欧密, 李瑞, 吕凤琳, 彭琳, 刘琳, 胡礼炳, 王春晖. 老年根治性膀胱切除术病人衰弱风险的研究进展[J]. 实用老年医学, 2022, 36(11): 1162-1165.
[6]	蒋小曼, 丁玲玉, 朱涵菲, 徐欣怡, 许勤. 老年人衰弱与代谢综合征关系的研究进展[J]. 实用老年医学, 2022, 36(10): 1054-1057.
[7]	徐静, 李娇娇, 陈雅, 王丽. 社区老年人功能性体适能现状及与慢性病共病的相关性分析[J]. 实用老年医学, 2022, 36(9): 897-901.
[8]	杨君红, 梁兰玉, 单清. 预后营养指数对老年重症COPD病人预后的预测价值[J]. 实用老年医学, 2022, 36(9): 911-915.
[9]	袁胜楠, 周静, 李敏,. 知觉压力在住院老年病人自我忽视与衰弱间的中介作用[J]. 实用老年医学, 2022, 36(9): 920-923.
[10]	王佳贺. 前言—老年人常见社区急症的临床特点及治疗[J]. 实用老年医学, 2022, 36(8): 757-758.
[11]	董星娜, 邬真力. 老年人晕厥的临床特点及诊疗进展[J]. 实用老年医学, 2022, 36(8): 759-761.
[12]	骆涵泳, 李铭麟, 崔檬, 王佳贺. 老年人常见社区急症—呼吸困难的临床特点及治疗[J]. 实用老年医学, 2022, 36(8): 762-765.
[13]	宫铭, 张成普. 老年人常见创伤的临床特点及治疗[J]. 实用老年医学, 2022, 36(8): 766-770.
[14]	辜圆媛, 刘焕兵. 社区老年人呕血的临床特点及治疗[J]. 实用老年医学, 2022, 36(8): 771-775.
[15]	李铭麟, 李诞, 骆涵泳, 王佳贺. 老年人常见社区急性中毒的临床特点及治疗[J]. 实用老年医学, 2022, 36(8): 776-779.